Clinical trial
Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
NCT00005926 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00005926 |
|---|---|
| Title | Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas |
| Official title | A Phase II Trial of Gemcitabine, Herceptin, and Radiation for Regionally Confined Adenocarcinoma of the Pancreas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer, Pancreatic Neoplasm |
| Intervention type | Drug, Procedure |
| Interventions | Gemcitabine, Herceptin, Radiation therapy |
| Enrollment | 50 |
| Start date | Jun 1, 2000 |
| Completion | Dec 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: